Zyla Life Sciences Long-term Debt, Gross
Zyla Life Sciences had Long-term Debt, Gross of $108.74 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2020-05-14
- 2020-03-31: Long-term Debt, Gross $108.74M.
- 2019-12-31: Long-term Debt, Gross $109.74M.
- 2019-09-30: Long-term Debt, Gross $110.27M.
- 2019-06-30: Long-term Debt, Gross $110.16M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2020-03-31 | $108.74M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $109.74M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $110.27M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $110.16M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $110.28M 10-Q · filed 2019-05-17 |